Thiated derivatives of 2′,3′-dideoxy-3′-fluorothymidine: Synthesis, in vitro anti-HIV-1 activity and interaction with recombinant drug resistant HIV-1 reverse transcriptase forms

被引:3
作者
Miazga, Agnieszka [1 ]
Hamy, Francois [2 ]
Louvel, Severine [2 ]
Klimkait, Thomas [2 ]
Pietrusiewicz, Zofia [3 ]
Kurzynska-Kokorniak, Anna [3 ]
Figlerowicz, Marek [3 ]
Winska, Patrycja [1 ]
Kulikowski, Tadeusz [1 ]
机构
[1] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland
[2] InPheno AG, CH-4051 Basel, Switzerland
[3] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland
关键词
Anti HIV-1 agents; NRTI; HIV-1; mutants; NUCLEOSIDE ANALOGS; DNA; INHIBITION; 3'-FLUOROTHYMIDINE; 5'-TRIPHOSPHATES; PHOSPHORYLATION; TRIPHOSPHATE; TOXICITY; CELLS;
D O I
10.1016/j.antiviral.2011.05.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Various thiated analogues of thymine 2',3'-dideoxy-3'-fluoronucleoside (FLT) and their 5'-monophosphates and 5'-triphosphates were prepared with the use of modified multistep procedures. The thiated analogues of FLT and FLTMP were evaluated against the wild type and drug- and multidrug-resistant strains of HIV-1, using the replicative phenotyping format of the deCIPhR assay, and showed potent inhibition of drug-resistant HIV-1 strains at low cytotoxicity. Additionally, inhibition of recombinant drug resistant forms of reverse transcriptase from single and multiple HIV-1 mutants by the synthesized 5'-triphosphates was investigated. The strongest inhibition was observed for K103N and Delta 67 mutants and the most potent anti-HIV-1 activity against drug resistant strains and the lowest cytotoxicity was exerted by S(4)FLTMP and FLTMP which may be regarded as potential anti-HIV/AIDS agents. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 23 条
  • [1] The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance
    Acosta-Hoyos, Antonio J.
    Scott, Walter A.
    [J]. VIRUSES-BASEL, 2010, 2 (02): : 372 - 394
  • [2] ANTI-RETROVIRUS ACTIVITY OF 3'-FLUORO-SUBSTITUTED AND 3'-AZIDO-SUBSTITUTED PYRIMIDINE 2',3'-DIDEOXYNUCLEOSIDE ANALOGS
    BALZARINI, J
    BABA, M
    PAUWELS, R
    HERDEWIJN, P
    DECLERCO, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (14) : 2847 - 2856
  • [3] Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients
    Becher, F
    Pruvost, AG
    Schlemmer, DD
    Créminon, CA
    Goujard, CM
    Delfraissy, JF
    Benech, HC
    Grassi, JJ
    [J]. AIDS, 2003, 17 (04) : 555 - 561
  • [4] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [5] CHENG YC, 1987, J BIOL CHEM, V262, P2187
  • [6] 3'-FLUORO-2',3'-DIDEOXYRIBONUCLEOSIDE 5'-TRIPHOSPHATES - TERMINATORS OF DNA-SYNTHESIS
    CHIDGEAVADZE, ZG
    SCAMROV, AV
    BEABEALASHVILLI, RS
    KVASYUK, EI
    ZAITSEVA, GV
    MIKHAILOPULO, IA
    KOWOLLIK, G
    LANGEN, P
    [J]. FEBS LETTERS, 1985, 183 (02) : 275 - 278
  • [7] Clark AD, 1995, METHOD ENZYMOL, V262, P171, DOI 10.1016/0076-6879(95)62017-6
  • [8] Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
    Fehr, Jan
    Glass, Tracy R.
    Louvel, Severine
    Hamy, Francois
    Hirsch, Hans H.
    von Wyl, Viktor
    Boeni, Juerg
    Yerly, Sabine
    Buergisser, Philippe
    Cavassini, Matthias
    Fux, Christoph A.
    Hirschel, Bernard
    Vernazza, Pietro
    Martinetti, Gladys
    Bernasconi, Enos
    Guenthard, Huldrych F.
    Battegay, Manuel
    Bucher, Heiner C.
    Klimkait, Thomas
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [9] NUCLEOSIDES .158. FLUORINATED SUGAR ANALOGS OF POTENTIAL ANTI-HIV-1 NUCLEOSIDES
    HUANG, JT
    CHEN, LC
    WANG, L
    KIM, MH
    WARSHAW, JA
    ARMSTRONG, D
    ZHU, QY
    CHOU, TC
    WATANABE, KA
    MATULICADAMIC, J
    SU, TL
    FOX, JJ
    POLSKY, B
    BARON, PA
    GOLD, JWM
    HARDY, WD
    ZUCKERMAN, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (05) : 1640 - 1646
  • [10] Anti-HIV type 1 activity of 3′-fluoro-3′-deoxythymidine for several different multidrug-resistant mutants
    Kim, EY
    Vrang, L
    Öberg, B
    Merigan, TC
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (05) : 401 - 407